Literature DB >> 4009450

Stability of melphalan solutions during preparation and storage.

A G Bosanquet.   

Abstract

A stability-indicating high-performance liquid chromatographic assay has been used to investigate the stability of solutions of melphalan under conditions that pertain to setting up in vitro chemosensitivity assays. Melphalan (1 and 20 micrograms/mL) was found to be 30% more stable in 150 mM NaCl solution (normal saline) than in Dulbecco's phosphate-buffered saline. The drug stored at 20 micrograms/mL in normal saline at room temperature (21.5 degrees C) lost 5% of its activity (t0.95) in 1.5 h; at 5 degrees C the t0.95 was 20 h. From an Arrhenius plot of the results, the activation energy of the hydrolysis reaction in normal saline was 100.2 kJ/mol. Less than 5% of drug activity was lost when solutions of melphalan were (a) stored at -20 degrees C and -35 degrees C for 7 months, (b) frozen and thawed up to four times, or (c) filtered through various membranes. Drug degradation was not affected by storage-container material. The half-life of melphalan in a Roswell Park Memorial Institute medium containing 10% fetal bovine serum at 37 degrees C was 1.13 +/- 0.10 h; the presence of 0.3% agar had no effect. It is suggested that melphalan be handled at temperatures greater than 5 degrees C for a minimum of time, but solutions of the drug can be stored for at least 6 and possibly up to 12 months at -20 degrees C without significant deterioration taking place.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4009450     DOI: 10.1002/jps.2600740329

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

Review 1.  Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. II. Assay methods, adriamycin and the other antitumour antibiotics.

Authors:  A G Bosanquet
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

2.  Interaction of cimetidine with oral melphalan. A pharmacokinetic study.

Authors:  L Sviland; A Robinson; S J Proctor; D N Bateman
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

3.  Chlorambucil: stability of solutions during preparation and storage.

Authors:  A G Bosanquet; H E Clarke
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

4.  Degradation of melphalan in vitro: rationale for the use of continuous exposure in chemosensitivity assays.

Authors:  A G Bosanquet; M C Bird
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

5.  The effect of hyperthermia in combination with melphalan on drug-sensitive and drug-resistant CHO cells in vitro.

Authors:  D A Bates; W J Mackillop
Journal:  Br J Cancer       Date:  1990-08       Impact factor: 7.640

6.  Stability of Melphalan in 0.9% Sodium Chloride Solutions Prepared in Polyvinyl Chloride Bags for Intravenous Injection.

Authors:  Romain-Pacôme Desmaris; Lionel Mercier; Angelo Paci
Journal:  Drugs R D       Date:  2015-09

7.  An inverse switch in DNA base excision and strand break repair contributes to melphalan resistance in multiple myeloma cells.

Authors:  Mirta M L Sousa; Kamila Anna Zub; Per Arne Aas; Audun Hanssen-Bauer; Aida Demirovic; Antonio Sarno; Erming Tian; Nina B Liabakk; Geir Slupphaug
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.